Dexcel Pharma Technologies Ltd. - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Intec Parent Inc (NTEC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intec Parent Inc (NTEC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Intec Parent Inc (NTEC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Dexcel Pharma Technologies Ltd. made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .

In summary, during the past 3 months, insiders sold 34,097 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 34,097 shares. During the past 18 months, 34,097 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 34,097 shares.

Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sio Gene Therapies Inc (SIOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sio Gene Therapies Inc (SIOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sio Gene Therapies Inc (SIOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Dexcel Pharma Technologies Ltd. made no insider transaction in Myovant Sciences Ltd (MYOV). Other recent insider transactions involving Myovant Sciences Ltd (MYOV) include a net sale of 4,051 shares made by Matthew Lang , a net sale of 3,360 shares made by Ferreira Juan Camilo Arjona , and a net purchase of 51,599,200 shares made by Sumitomo Chemical Co., Ltd. .

In summary, during the past 3 months, insiders sold 0 shares of Myovant Sciences Ltd (MYOV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,697 shares of Myovant Sciences Ltd (MYOV) were sold and 51,599,200 shares were bought by its insiders, resulting in a net purchase of 51,579,503 shares.

Myovant Sciences Ltd (MYOV)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Urovant Sciences Ltd (UROV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Urovant Sciences Ltd (UROV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Urovant Sciences Ltd (UROV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Dexcel Pharma Technologies Ltd. made no insider transaction in Protalix BioTherapeutics Inc (PLX). Other recent insider transactions involving Protalix BioTherapeutics Inc (PLX) include a net purchase of 110,000 shares made by Aharon Schwartz , and a net purchase of 64,516 shares made by Dror Bashan .

In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 174,516 shares were bought by its insiders, resulting in a net purchase of 174,516 shares.

Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Dexcel Pharma Technologies Ltd. made no insider transaction in Roivant Sciences Ltd (ROIV). Other recent insider transactions involving Roivant Sciences Ltd (ROIV) include a net sale of 4,285,337 shares made by Eric Venker , a net sale of 458,143 shares made by Rakhi Kumar , and a net sale of 16,343,919 shares made by Softbank Vision Fund L.p. .

In summary, during the past 3 months, insiders sold 96,950 shares of Roivant Sciences Ltd (ROIV) in total and bought 0 shares, with a net sale of 96,950 shares. During the past 18 months, 118,336,398 shares of Roivant Sciences Ltd (ROIV) were sold and 4,000,000 shares were bought by its insiders, resulting in a net sale of 114,336,398 shares.

Roivant Sciences Ltd (ROIV)'s detailed insider trading history can be found in Insider Trading Tracker table.